Vectura Group (VEC)

Sector:

Pharma and Biotech

Index:

FTSE 250

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

113.10p
   
  • Change Today:
    -0.90p
  • 52 Week High: 163.00
  • 52 Week Low: 110.80
  • Currency: UK Pounds
  • Shares Issued: 679.34m
  • Volume: 755,104
  • Market Cap: 768.34m
  • RiskGrade: 108

Vectura Group Overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -35.2% n/a
ROCE n/a  
Latest F'cast
P/E 15.3 n/a
PEG 0.5 n/a
Pr/Revenue 4.6 n/a
Pr/Book 1.1  
Latest F'cast
Revenue 133.2% n/a
PBT n/a n/a
EPS 30.4% n/a
DPS n/a n/a

Vectura Group Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-13 30.50 (10.40) (1.80)p n/a n/a n/a n/a 0.0%
31-Mar-14 36.50 (4.80) 1.50p 102.2 n/a n/a n/a 0.0%
31-Mar-15 58.00 (6.20) 4.00p 36.4 0.2 +167% n/a 0.0%
31-Mar-16 72.00 (1.90) 5.70p 28.5 0.7 +42% n/a 0.0%
31-Dec-16 126.50 (40.10) 7.43p 18.4 0.6 +30% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Vectura Group Company Announcements

Hikma statement on generic Advair Diskus® (... 17-Aug-2017 07:06 RNS
Global development agreement with Dynavax 16-Aug-2017 07:00 RNS
Director/PDMR Shareholding 07-Aug-2017 13:02 RNS

Latest Vectura Group Director Deals

Traded Action Notifier PriceAmountValue
04-Aug-17 Buy Andrew Derodra 111.30p 135 150.26
06-Jun-17 Buy Andrew Derodra 111.30p 135 150.26

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Vectura Group Market Data

Currency UK Pounds
Share Price 113.10p
Change Today -0.90p
% Change -0.79 %
52 Week High 163.00
52 Week Low 110.80
Volume 755,104
Shares Issued 679.34m
Market Cap 768.34m
RiskGrade 108

Vectura Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.22% above the market average5.22% above the market average5.22% above the market average5.22% above the market average5.22% above the market average
68.97% above the sector average68.97% above the sector average68.97% above the sector average68.97% above the sector average68.97% above the sector average
Price Trend
79.07% below the market average79.07% below the market average79.07% below the market average79.07% below the market average79.07% below the market average
51.61% below the sector average51.61% below the sector average51.61% below the sector average51.61% below the sector average51.61% below the sector average
Income Not Available
Growth
87.53% above the market average87.53% above the market average87.53% above the market average87.53% above the market average87.53% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average

Vectura Group Dividends

No dividends found

Trades for 17-Aug-2017

Time Volume / Share Price
16:06 1,300 @ 113.10p
16:06 584 @ 113.10p
16:06 716 @ 113.10p
16:06 1,170 @ 113.20p
16:06 80 @ 113.20p

Vectura Group Key Personnel

CEO Chris Blackwell
CEO James Ward-Lilley
CFO Andrew Derodra

Top of Page